Phase 2 EL219 Versus Liposomal Amphotericin B or Voriconazole for Early Antifungal Therapy

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Phase 2 EL219 Versus Liposomal Amphotericin B or Voriconazole for Early Antifungal Therapy	Invasive Mould Infection	Recruiting	Phase 2	2026-10-05		NCT07215273

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Elion Therapeutics, Inc.	1

28 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
AP-HP Hopital Henri Modor	Créteil	France	1
AP-HP Hopital Saint-Louis	Paris	France	4
Augusta University Medical Center	Augusta	United States	117
AZ Sint-Jan Brugge	Bruges	Belgium	10
Centre Hospitalier D'Argenteuil	Argenteuil	France	3
Fondazione Policlinico Universitario A. Gemelli IRCCS- Universita Cattolica del Sacro Cuore	Roma	Italy	1
Hospital Clinic Barcelona	Barcelona	Spain	37
Hospital Clinico Universitario de Salamanca	Salamanca	Spain	30
Hospital del Mar	Barcelona	Spain	1
Hospital Universitario 12 de Octubre	Madrid	Spain	359
Hospital Universitario Puerta de Hierro	Majadahonda	Spain	10
Hospital Universitario Vall D'Hebron	Barcelona	Spain	86
Istituto Europeo Di Oncologia	Milan	Italy	70
John Hopkins University	Baltimore	United States	14
Juravinski Hospital	Hamilton	Canada	11
Massachusetts General Hospital	Boston	United States	1015
U. of Alabama at Birmingham	Birmingham	United States	1
U. of Michigan	Ann Arbor	United States	1
U. of Texas Health Sciences Center at San Antonio	San Antonio	United States	1
U. of Texas, MD Anderson	Houston	United States	1
U. of Washington	Seattle	United States	1
UC Davis Medical Center	Sacramento	United States	63
Universite Libre de Bruxelles (ULB) - Institut Jules Bordet	Brussels	Belgium	2
University Health Network (UHN) - Princess Margaret Cancer Centre	Toronto	Canada	1
UZ Gent	Ghent	Belgium	113

Clinical trials